PRESS RELEASE published on 07/24/2025 at 14:40, 4 months 28 days ago Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris. La société de biotechnologie se concentre sur le développement de traitements thérapeutiques pour les maladies inflammatoires chroniques Euronext Paris Biotechnologie Abivax Traitements Thérapeutiques Maladies Inflammatoires
PRESS RELEASE published on 07/24/2025 at 14:40, 4 months 28 days ago Abivax annonce les modalités définitives de l’offre au public de 650M$ (554M€) d’American Depositary Shares Abivax annonce les modalités définitives de l’offre au public de 650M$ (554M€) d’American Depositary Shares pour financer le développement de thérapies biotechnologiques. Details de l'offre, stabilisation et prévisions financières Biotechnologie Abivax Ads Offre Publique Modalités Définitives
PRESS RELEASE published on 07/24/2025 at 14:40, 4 months 28 days ago Abivax announces trading resumption of its ordinary shares on Euronext Paris Abivax announces the trading resumption of its ordinary shares on Euronext Paris after a temporary halt for a public offering confirmation and pricing announcement Euronext Paris Abivax Public Offering Clinical-stage Biotechnology Trading Resumption
PRESS RELEASE published on 07/24/2025 at 14:40, 4 months 28 days ago Custodian Property Income REIT plc: Interim dividend Custodian Property Income REIT plc declares its first quarterly interim dividend for the financial year 2026 on 1.5 pence per share, enhancing income return from UK properties Dividend Custodian Property Income REIT Income Return UK Properties Financial Year 2026
PRESS RELEASE published on 07/24/2025 at 14:40, 4 months 28 days ago Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris. La société de biotechnologie se concentre sur le développement de traitements pour les maladies inflammatoires chroniques Euronext Paris Biotechnologie Abivax Négociations Traitements
PRESS RELEASE published on 07/24/2025 at 14:40, 4 months 28 days ago Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares Abivax announces pricing of $650M (€554M) public offering of American Depositary Shares to fund clinical development and working capital, with expected closing on July 28, 2025 Abivax Clinical Development Public Offering Pricing Closing
PRESS RELEASE published on 07/24/2025 at 14:40, 4 months 28 days ago Abivax annonce les modalités définitives de l’offre au public de 650M$ (554M€) d’American Depositary Shares Abivax annonce les modalités de son offre de 650M$ d'American Depositary Shares pour financer des développements cliniques. Stabilisation et options incluses Abivax Développement Clinique Offre Publique Stabilisation American Depositary Shares
PRESS RELEASE published on 07/24/2025 at 14:30, 4 months 28 days ago High level of approval at the Annual General Meeting - vote of confidence in the Netfonds AG's strategy Netfonds AG's Annual General Meeting sees high level of approval, demonstrating shareholders' confidence in company's strategy. Approval rate of 99.99% for balance sheet profit appropriation Annual General Meeting Shareholders Netfonds AG Strategy Approval
PRESS RELEASE published on 07/24/2025 at 14:21, 4 months 28 days ago EQS-Adhoc: CECONOMY AG: CECONOMY AG confirms advanced negotiations with JD.com CECONOMY AG confirms advanced negotiations with JD.com for possible public takeover. No binding agreements signed yet Acquisitions Negotiations Takeover CECONOMY AG JD.com
PRESS RELEASE published on 07/24/2025 at 14:11, 4 months 28 days ago EQS-Adhoc: FUTRUE GmbH submits request to implement squeeze-out of minority shareholders of PharmaSGP Holding SE FUTRUE GmbH requests squeeze-out of minority shareholders by PharmaSGP Holding SE as it holds over 95% shares. Valuation ongoing for cash compensation determination Squeeze-out Minority Shareholders Cash Compensation PharmaSGP Holding SE Futrue GmbH
Published on 12/20/2025 at 00:30, 2 days 3 hours ago Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 2 days 6 hours ago GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 2 days 9 hours ago Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 2 days 13 hours ago Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 2 days 14 hours ago Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Published on 12/22/2025 at 00:35, 3 hours 32 minutes ago Samsung to Host Series of Tech Forums at CES 2026
Published on 12/22/2025 at 00:05, 4 hours 2 minutes ago Samsung To Unveil AI Vision Built With Google Gemini at CES 2026
Published on 12/21/2025 at 08:55, 19 hours 12 minutes ago Vantage Markets recognised for real-time threat intelligence collaboration with Trend Micro
Published on 12/20/2025 at 16:45, 1 day 11 hours ago Shanghai Electric Powers Up Iraq's Energy Future with Major 625MW Efficiency Upgrade
Published on 12/20/2025 at 10:05, 1 day 18 hours ago FITUR 2026 highlights the strong synergies between Germany and Spain
Published on 12/19/2025 at 21:57, 2 days 6 hours ago Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 2 days 19 hours ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 2 days 19 hours ago Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 2 days 21 hours ago EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 2 days 21 hours ago EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION